A monoclonal melanoma-specific T-cell population phenotypically indistinguishable from CD3+ LGL-leukemia [3]

Blood

Volumn 101, Issue 11, 2003, Pages 4643-4644

  Valmori, Danila ^a   Ayyoub, Maha ^b   Hesdorffer, Charles S ^b   Keilholz, Ulrich ^b   Scheibenbogen, Carmen ^b  

^a Columbia Univ Coll of Phys/Surgs ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN;

AUTOIMMUNE DISEASE; CANCER PATIENT; CLINICAL FEATURE; DATA ANALYSIS; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; LETTER; MELANOCYTE; MELANOMA; NEUTROPENIA; PHENOTYPE; PRIORITY JOURNAL; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; CELL CLONE; IMMUNOLOGY; IMMUNOPHENOTYPING; PATHOLOGY;

ANTIGENS, CD3; CLONE CELLS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, T-CELL; MELANOMA; T-LYMPHOCYTES;

EID: 0038142341     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-03-0828     Document Type: Letter

References (7)

1. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
2. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP Jr. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;89:256-260.
3. Pandolfi F, Loughran TP Jr, Starkebaum G, et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes: a multicenter study. Cancer. 1990;65:341-348.
4. Richards SJ, Short M, Scott CS. Clonal CD3+CD8+ large granular lymphocyte (LGL)/NK-associated (NKa) expansions: primary malignancies or secondary reactive phenomena? Leuk Lymphoma. 1995;17:303-311.
5. Bigouret V, Hoffmann T, Arlettaz L, et al. Monoclonal T cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94-NKG2C/E and NKD2D killer cell receptors. Blood. 2002;101:3198-3204.
6. Valmori D, Scheibenbogen C, Dutoit V, et al. Circulating tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activity. Cancer Res. 2002;62:1743-1750.
7. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13:230-240.